overview of the fda product-specific guidance program
Published 3 years ago • 1.4K plays • Length 13:21Download video MP4
Download video MP3
Similar videos
-
12:57
product specific guidances webinar – opening remarks
-
14:41
product-specific guidance fundamentals from a clinical perspective
-
34:44
fda fish and fishery products and hazards controls guidance, 4th edition: introduction and overview
-
19:10
product-specific guidances for complex generic drugs
-
54:40
otc monograph reform overview of draft guidance for formal meetings
-
41:31
pre-approval inspections: what to expect when being inspected (15of15) redi – may 29-30, 2019
-
27:33
how does fda execute pre- and post-approval inspections? (7of33) quality – oct. 16-17, 2019
-
52:19
facility readiness: gmps, quality assessments, and compliance trends (15of16) gdf 2020
-
20:56
pre-anda program overview (2of39) complex generics 2018
-
15:51
model informed drug development approaches for immunogenicity assessments workshop
-
1:32:21
latest research: consumer products, lead exposure, and prioritizing solutions in the us and abroad
-
19:31
an overview of pre-license inspections for biotech products (5/15) global quality
-
40:35
product specific guidances (psgs) (3of16) generic drugs forum 2020
-
53:23
fda webinar on the infant formula transition plan for exercise of enforcement discretion (part 1)
-
34:41
complex product characterization/analysis - session 2a
-
47:42
generic combination products: assessment and regulatory update (14of16) gdf 2020
-
46:47
pre-anda logistics and best practices (3of39) complex generics 2018
-
46:22
best practices for proprietary name design – pharmacovigilance 2020
-
1:21
what does fda regulate?
-
24:56
api facility inspections
-
55:40
nonprescription drug product with an additional condition for nonprescription use
-
31:16
fda guidance on conduct of clinical trials of medical products during the public health emergency